KEYNOTE PRESENTATION: Engineering Myeloid Cells to Find, Recognize, & Penetrate Tumors, & Prime the Immune System to Enforce an Anti-Tumor Response

Time: 8:00 am
day: Day One


• Discussing why myeloid cells are an attractive therapeutic target in solid and hematological conditions, with their frequent migration into solid tumors, bone marrow, and inflammation sites

• Directing phagocytic properties of myeloid cells to recognize and engulf cancer cells

• Bridging innate and adaptive immunity to elicit a comprehensive anti-tumor response

• Empowering myeloid cells to produce anti-tumor agenda and modify the tumor microenvironment